Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder

ConclusionsIn this preliminary trial vortioxetine appears safe and effective for patients with MDD comorbid with SAD, with robust effect sizes on dimensional measures of both depression and social anxiety, but failure to separate from placebo on the primary outcome measure of composite responder rate. More studies of patients with comorbid conditions are needed, as this mirrors what is often seen in clinical practice.
Source: Depression and Anxiety - Category: Psychiatry Authors: Tags: RESEARCH ARTICLE Source Type: research